All over the world, pharma / biotech industries are facing a paradigm shift that poses major challenges related to promotion of their products. They have to assume about devoted health care professionals, rigorous administration managers, scientific societies more vigilant and better informed patients. Thus, in addition to try of finding improvement of patient's quality of life, the concept "Science to Business" should now be considered: high-quality scientific product marketing for preferential market access.
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
